Yesterday, startup LifePlus exited stealth mode to reveal what it claims to be the first noninvasive continuous blood glucose monitoring multi-sensor wearable, called LifeLeaf. Although details are scare on exactly how the technology works, the company said the product is being tested in five clinical trials around the world.
from MobiHealthNews https://ift.tt/2wT0K3I
May 18, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Free app Welloh offers patients tool to find providersConsumers now have another option to turn to when looking for a new doctor with the recent launch of mobile provider search tool Welloh. The free app is designed to help users navigate their healthcare options. It … Read More
Judge dismisses Opternative's suit against South Carolina eye care lawIn 2016, Opternative, a Chicago-based telehealth startup offering online refractive eye exams, opened a lawsuit against South Carolina’s Board of Medical Examiners and Department of Labor, Licensing, and Regulation alleging t… Read More
HIMSS Precision Medicine Summit — Call for Speaking Proposals OpenHIMSS is now accepting speaking proposals for the Precision Medicine Summit, May 17-18 in Washington, DC. Precision medicine is one of the hottest and most transformative topics in healthcare, and over two days, speakers will… Read More
Chatbot campaign for flu shots bolsters patient response rate by 30%Communicating with patients can be tough. Reminder pamphlets often go straight into the rubbish and emails are deleted before they are read. But one doctor found that chatbots could be a key to patient outreach. Brett S… Read More
Amazon, Berkshire, JPMorgan Chase partner to build healthcare company with focus on techAmazon, the world’s ubiquitous online store, revealed today it is collaborating with Warren Buffet, who heads Berkshire Hathaway, and the bank JPMorgan Chase to build an independent, nonprofit healthcare company with the goal… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment